Patents by Inventor Abulaish Ansari

Abulaish Ansari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA-541-3P AS A THERAPEUTIC AGENT AS WELL AS ZNF101 AND CASZ1 AS THERAPEUTIC TARGETS TO LOWER PLASMA LDL-C, INCREASE PLASMA HDL-C, AND REDUCE ATHEROSCLEROSIS
    Publication number: 20240401048
    Abstract: Provided are compositions and methods for lowering plasma LDL-C, increasing plasma HDL-C, and reducing atherosclerosis. The methods include administering to an individual in need miRNA-541-3P or a modified version thereof, or an agent other than the miRNA-541-3P or the modified version thereof that inhibits the function or expression of ZNF101 or CASZ1, or a combination thereof. Performing a method also decreases expression of apoB increases expression of apoA1 is increased.
    Type: Application
    Filed: June 5, 2024
    Publication date: December 5, 2024
    Inventors: Abulaish Ansari, Pradeep Kumar Yadav, M. Mahmood Hussain